PILOT
831175
XINGANJIANG
873167
Beijing Highlander Digital Technology
300065
4
Hangzhou Gaoxin Materials Technology
300478
5
Shijihengtong Technology
301428
US Stock MarketDetailed Quotes
CRSP CRISPR Therapeutics
- 49.720
- +6.230+14.33%
Close Feb 14 16:00 ET
- 49.930
- +0.210+0.42%
Post 20:01 ET
4.26BMarket Cap-11.46P/E (TTM)
52.600High46.040Low7.75MVolume46.210Open43.490Pre Close385.82MTurnover9.23%Turnover RatioLossP/E (Static)85.77MShares90.62052wk High2.21P/B4.17BFloat Cap36.52052wk Low--Dividend TTM83.93MShs Float220.200Historical High--Div YieldTTM15.08%Amplitude11.630Historical Low49.814Avg Price1Lot Size
CRISPR Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 45.17%-142.77M | 47.92%-50.03M | -168.25%-106.91M | 28.27%-95.58M | 1,147.32%109.75M | 47.48%-260.38M | 15.23%-96.07M | 62.12%-39.86M | 6.14%-133.25M | 106.51%8.8M |
| Net income from continuing operations | -138.43%-366.25M | -141.76%-37.31M | 23.37%-85.94M | -62.60%-126.41M | -119.71%-116.59M | 76.37%-153.61M | 180.80%89.35M | 35.75%-112.15M | 58.17%-77.74M | 70.39%-53.07M |
| Depreciation and amortization | -2.91%19.26M | -1.18%4.84M | -3.78%4.74M | -2.34%4.85M | -4.32%4.83M | -17.93%19.84M | -16.18%4.9M | -1.85%4.93M | -31.75%4.96M | -16.36%5.05M |
| Other non cash items | -174.96%-38.62M | -217.98%-15.16M | -33.69%-6.9M | -159.63%-8.18M | -765.33%-8.39M | -212.63%-14.05M | -2,276.26%-4.77M | -299.96%-5.16M | -188.21%-3.15M | -115.89%-969K |
| Change In working capital | 180.72%156.27M | 88.06%-24.35M | -176.78%-40.36M | 113.27%10.49M | 470.33%210.49M | -1,075.49%-193.59M | -545.02%-203.97M | 41.34%52.56M | -1,066.16%-79.08M | 505.53%36.91M |
| -Change in receivables | 187.50%175M | 87.50%-25M | --0 | --0 | --200M | -65,673.77%-200M | -408,263.27%-200M | 411,664.71%70M | -91,009.09%-70M | --0 |
| -Change in prepaid assets | -77.24%5.29M | -97.27%176K | -123.01%-188K | -39.98%2.35M | -75.51%2.95M | 1,353.00%23.22M | 218.05%6.45M | -83.76%817K | 251.69%3.91M | 161.11%12.04M |
| -Change in payables and accrued expense | -34.75%-27.28M | 14.59%-7.85M | -54.53%-38.16M | 180.17%9.28M | -62.55%9.44M | -492.08%-20.25M | 70.44%-9.19M | -188.32%-24.69M | -216.72%-11.58M | 1,660.27%25.21M |
| -Change in other current liabilities | 8,649.09%9.62M | 1,316.31%9.99M | 128.18%31K | 112.70%40K | -154.12%-432K | 107.23%110K | 7.80%705K | 89.29%-110K | 68.31%-315K | -10.39%-170K |
| -Change in other working capital | -290.70%-6.36M | 14.09%-1.67M | -131.19%-2.04M | -7.18%-1.18M | -730.51%-1.47M | -76.69%3.33M | -145.76%-1.94M | 25.68%6.55M | -162.43%-1.1M | -105.72%-177K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 45.17%-142.77M | 47.92%-50.03M | -168.25%-106.91M | 28.27%-95.58M | 1,147.32%109.75M | 47.48%-260.38M | 15.23%-96.07M | 62.12%-39.86M | 6.14%-133.25M | 106.51%8.8M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -174.87%-280.48M | 229.93%105.83M | -233.17%-161.6M | -158.50%-126.91M | -183.00%-97.8M | 244.84%374.65M | 53.60%-81.45M | 38.74%121.35M | 486.87%216.92M | 202.89%117.83M |
| Net PPE purchase and sale | 79.93%-1.9M | 65.58%-254K | 89.66%-219K | 80.11%-707K | 76.43%-721K | 74.53%-9.47M | 88.08%-738K | 64.80%-2.12M | 63.08%-3.56M | 80.07%-3.06M |
| Net intangibles purchase and sale | --0 | --0 | --0 | ---- | ---- | ---2.5M | --0 | ---1M | ---- | ---- |
| Net investment purchase and sale | -172.06%-278.58M | 231.43%106.08M | -229.66%-161.39M | -156.85%-126.2M | -180.30%-97.08M | 274.57%386.62M | 52.34%-80.72M | 33.15%124.47M | 577.97%221.98M | 221.91%120.89M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -174.87%-280.48M | 229.93%105.83M | -233.17%-161.6M | -158.50%-126.91M | -183.00%-97.8M | 244.84%374.65M | 53.60%-81.45M | 38.74%121.35M | 486.87%216.92M | 202.89%117.83M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 429.78%331.98M | -56.66%16.88M | 519.54%9.64M | -102.78%-466K | 5,561.25%305.93M | 62.38%62.66M | 1,471.39%38.94M | -89.70%1.56M | 61.93%16.77M | -49.25%5.4M |
| Net common stock issuance | 818.97%300.7M | -54.28%14.96M | --6M | ---1.01M | --280.75M | 3,273.30%32.72M | --32.72M | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | 4.50%31.29M | -69.17%1.92M | 133.74%3.64M | -96.74%546K | 366.12%25.19M | -20.41%29.94M | 150.93%6.22M | -89.00%1.56M | 61.93%16.77M | -49.25%5.4M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 429.78%331.98M | -56.66%16.88M | 519.54%9.64M | -102.78%-466K | 5,561.25%305.93M | 62.38%62.66M | 1,471.39%38.94M | -89.70%1.56M | 61.93%16.77M | -49.25%5.4M |
| Net cash flow | ||||||||||
| Beginning cash position | 79.00%401.07M | -56.04%237.19M | 8.63%495.99M | 101.88%718.94M | 79.00%401.07M | -76.16%224.06M | 5.74%539.6M | -11.01%456.6M | -49.18%356.12M | -76.16%224.06M |
| Current changes in cash | -151.58%-91.27M | 152.44%72.67M | -411.72%-258.88M | -321.97%-222.95M | 140.76%317.89M | 124.72%176.94M | 51.61%-138.59M | 3,243.38%83.05M | 153.52%100.44M | 155.22%132.03M |
| Effect of exchange rate changes | -128.77%-21K | -242.62%-87K | 256.25%75K | -92.86%2K | -134.38%-11K | 191.25%73K | -46.96%61K | 52.00%-48K | 141.18%28K | 218.52%32K |
| End cash Position | -22.76%309.78M | -22.76%309.78M | -56.04%237.19M | 8.63%495.99M | 101.88%718.94M | 79.00%401.07M | 79.00%401.07M | 5.74%539.6M | -11.01%456.6M | -49.18%356.12M |
| Free cash flow | 46.88%-144.68M | 48.06%-50.29M | -149.29%-107.13M | 30.38%-96.29M | 1,799.49%109.03M | 48.90%-272.35M | 19.00%-96.81M | 61.37%-42.97M | 8.76%-138.3M | 103.81%5.74M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Trending Stocks
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call